What this study is
The aim of the project is to collect pre-procedural CT scans, intra-procedural post-evacuation scans as well as immediate post-procedural CT scans to evaluate and collect feedback of two Siemens prototypes: 1) perfusion prototype and 2) automatic hemorrhage detection prototype. The assessment of the prototypes, including its features will focus on the feasibility, usefulness as well as the potential clinical value add in minimally invasive ICH treatment.
What's being tested
- DynaCT Multiphase
Intervention · DEVICE
DynaCT Multiphase device is the perfusion prototype scan. DynaCT Multiphase scans taken intra-operatively will be processed offsite on Siemens' hemorrhage detection and perfusion prototypes.
- DynaCT Sine Spin
Intervention · DEVICE
DynaCT Sine Spin scan is the automatic hemorrhage detection prototype. Scans taken intra-operatively will be processed offsite on Siemens' hemorrhage detection and perfusion prototypes.
Study details
- Official title
- Feasibility of the Utilization of Siemens Prototypes in Minimally Invasive ICH Evacuation Treatment
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Conditions
- Intracerebral Hemorrhage
- Enrolling
- 15 people
- Starts
- 2025-10-31
- Est. completion
- 2028-12-31
- Design
- Open-label, single group
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- Patient ≥ 18 years old
- Patient is planned to undergo minimally invasive hemorrhage evacuation at Mount Sinai West Hospital
You can't join if
- Patient is < 18 years old
- Patient is not planned to undergo minimally invasive hemorrhage evacuation at Mount Sinai West Hospital
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openMount Sinai West
New York, New York, United States
- Christopher Kellner · Principal investigator
Recruiting
Study team
Sponsor
Icahn School of Medicine at Mount Sinai
Study ID STUDY-25-00145
Principal investigator
Christopher Kellner
Icahn School of Medicine at Mount Sinai
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.